Last deal

Amount

Seed

Stage

11.03.2024

Date

3

all rounds

$1.5M

Total amount

General

About Company
RealSeq Biosciences develops innovative technologies for bias-free small RNA/miRNA NGS library construction.

Industry

Sector :

Subsector :

Also Known As

RealSeq

founded date

01.01.2019

Number of employees

Last funding type

Seed

IPO status

Private

Description

The company specializes in developing proprietary technologies for small RNA/miRNA NGS library construction, targeted NGS tools, and cf-RNA analysis for liquid biopsy. These technologies form the basis of their life science research programs and product development.
Contacts